丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01513 丽珠医药

已收盘 09-09 16:08:06

21.240

+0.220

+1.05%

最高21.360	最低20.900	成交量126.91万
今开21.000	昨收21.020	日振幅2.19%
总市值188.61亿	流通市值63.72亿	总股本8.88亿
成交额2,692万	换手率0.42%	流通股本3.00亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01513","market":"HK","secType":"STK","nameCN":"丽珠医药","latestPrice":21.24,"timestamp":1788941286004,"preClose":21.02,"halted":0,"volume":1269100,"delay":0,"changeRate":0.010466222645099851,"floatShares":300000000,"shares":888000000,"eps":2.654952127033915,"marketStatus":"已收盘","change":0.22,"latestTime":"09-09 16:08:06","open":21,"high":21.36,"low":20.9,"amount":26918872,"amplitude":0.021884,"askPrice":21.26,"askSize":28500,"bidPrice":21.24,"bidSize":25400,"shortable":3,"etf":0,"ttmEps":2.202706178216036,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789003800000},"marketStatusCode":5,"adr":0,"listingDate":1389801600000,"exchange":"SEHK","adjPreClose":21.02,"dividendRate":0.077392,"openAndCloseTimeList":[[1788917400000,1788926400000],[1788930000000,1788940800000]],"volumeRatio":1.116035,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000513","market":"SZ","secType":"STK","nameCN":"丽珠集团","latestPrice":27.35,"timestamp":1788937200000,"preClose":27.22,"halted":0,"volume":6550800,"delay":0,"premium":"-33.60"}},"requestUrl":"/m/hq/s/01513","defaultTab":"news","newsList":[{"id":"1166322034","title":"丽珠医药（01513）公告9月15日线上参加广东辖区投资者集体接待日","url":"https://stock-news.laohu8.com/highlight/detail?id=1166322034","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166322034?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:02","pubTimestamp":1788944525,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司9月10日发布公告称，公司将参加由中国证券监督管理委员会广东监管局及广东上市公司协会主办、深圳市全景网络有限公司协办的“2026年广东辖区投资者集体接待日暨辖区上市公司中报业绩说明会”活动。交流时间定于2026年9月15日（周二）15:30-17:00。公司高管将就2026半年度业绩、公司治理、发展战略及经营状况等问题与投资者沟通。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101148142","title":"丽珠医药（01513.HK）拟派发9.06亿元中期现金红利 分红率97.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1101148142","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101148142?lang=zh_cn&edition=full","pubTime":"2026-09-08 18:01","pubTimestamp":1788861664,"startTime":"0","endTime":"0","summary":"9月9日，丽珠医药集团股份有限公司发布2026年半年度利润分配预案。公司于2026年9月8日召开第十二届董事会第三次会议，以10票同意、0票反对、0票弃权审议通过相关议案，方案尚待股东大会审议通过后实施。2026年上半年公司合并报表归属于上市公司股东的净利润为9.32亿元；本次现金分红金额占该项净利润的97.15%。公司表示，因法定公积金余额已超过注册资本50%，本期不再提取法定公积金及任意公积金。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186268031","title":"丽珠医药(01513)公布上半年分红方案：每10股派现10.20元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186268031","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186268031?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:55","pubTimestamp":1788861341,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司于2026年9月8日召开第十二届董事会第三次会议，并以书面传签方式审议通过《2026年半年度利润分配预案》等议案。会议应参与表决董事10人，实际参与表决董事10人，表决结果均为同意10票、反对0票、弃权0票，符合相关法规及《公司章程》规定。该方案尚需提交股东大会审议。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100112934","title":"丽珠医药（01513）将于9月24日召开第一次临时股东大会 审议2026年特别中期股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1100112934","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100112934?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:43","pubTimestamp":1788860591,"startTime":"0","endTime":"0","summary":"– 本次唯一普通决议将以投票方式表决，结果会在港交所网站及公司网站公布。– 股东可委任一名或多名代理人参会并投票，相关委托须在会议24小时前送达指定地点。– 会议预计持续约1小时，与会者交通及食宿费用自理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665298073","title":"丽珠医药(01513)拟派发特别中期股息每10股10.20元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665298073","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665298073?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:39","pubTimestamp":1788860343,"startTime":"0","endTime":"0","summary":"丽珠医药(01513)公布，2026年上半年公司整体保持了良好的经营情况及盈利水平，公司累计未分配利润较高，货币资金充足，资产负债结构稳定，现有资金可覆盖研发投入及日常经营需求等情况。为回报全体股东长期以来对公司的信任与支持，经董事会决议，公司拟派发特别中期股息每10股人民币10.20元(含税)，合计拟派发特别中期股息为约人民币9.06亿元(含税)。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg45.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg45.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4588","01513","BK4585","VIG","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394921","title":"港股异动 | 丽珠医药(01513)涨近3% 近日莱康奇塔单抗注射液正式获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394921","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665394921?lang=zh_cn&edition=full","pubTime":"2026-09-07 14:23","pubTimestamp":1788762183,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，丽珠医药(01513)涨近3%，截至发稿，涨2.55%，报20.9港元，成交额1528.46万港元。消息面上，近日，据丽珠医药官微消息，由公司的中国首个IL-17A/F双靶点创新生物制剂丽倍坦®(通用名：莱康奇塔单抗注射液)正式获批上市。国信证券指出，莱康奇塔单抗(IL-17A/F 抗体)在银屑病适应症与司库奇尤单抗头对头比较显示出优效，强直性脊柱炎适应症的临床3期研究取得良好的结果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01513","BK4588","VXUS","KCAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135578961","title":"丽珠医药（01513）披露2.6亿元新增子公司担保　已用担保余额占净资产12.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135578961","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135578961?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:26","pubTimestamp":1788510392,"startTime":"0","endTime":"0","summary":"9月5日，丽珠医药（01513）公告披露《关于为子公司提供担保的进展》。公司根据2026年3月24日董事会及5月29日股东会通过的《关于2026年度申请综合授信及担保额度预计的议案》，在今年8月与三家银行签订担保协议，为3家全资子公司提供连带责任保证，总计担保金额2.6亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163353605","title":"丽珠医药(01513)公告2026年首次临时股东会安排 9月18日为H股股东登记日","url":"https://stock-news.laohu8.com/highlight/detail?id=1163353605","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163353605?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:47","pubTimestamp":1788425264,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司9月3日发布公告称，公司预计于2026年9月24日(星期四)14时在中国广东省珠海市金湾区创业北路38号总部大楼六楼会议室召开2026年第一次临时股东会。公告指出，确定股东出席本次临时股东会并行使表决权的记录日期为2026年9月18日(星期五)。2026年9月18日名列股东名册的股东将有权出席会议并投票。会议审议议案的详细内容以届时发布的临时股东会通函为准。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109626900","title":"丽珠医药8月股份变动月报表，股本结构保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1109626900","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109626900?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:26","pubTimestamp":1788254801,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司（港股代码01513，深圳证券交易所主板代码000513）于2026年9月1日发布2026年8月股份变动月报表，报告期为2026年8月1日至2026年8月31日。\n根据公告，报告期内公司注册股本维持人民币887,907,171元不变；H股数量299,807,117股，A股数量588,100,054股，均与上月持平。公司当月无新增发行股票、购回、注销或库藏股变动，也无股份期权及其他股权激励计划的变动。\n截至2026年8月末，公司已满足相关公众持股量要求。公告由公司秘书刘宁签署。公司称，所有相关发行事项均严格遵守香港联合交易所有限公司《上市规则》及其他适用法律法规的要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073923","title":"智通AH统计|8月31日","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073923","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663073923?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:15","pubTimestamp":1788164105,"startTime":"0","endTime":"0","summary":"东北电气0.2422.251015.70%2.16%浙江世宝3.96016.58401.52%51.14%弘业期货2.2407.91322.77%14.23%中石化油服0.6602.29315.15%6.17%复旦张江2.5208.09284.52%6.86%晨鸣纸业0.6101.91275.41%18.37%凯盛新能2.2957.18274.73%24.65%安德利果汁22.20067.75265.54%-13.04%南京熊猫电子股份3.3159.73251.43%9.64%京城机电股份2.8508.29248.42%16.04%. 康希诺生物29.50085.36246.58%74.87%浙江世宝3.96016.58401.52%51.14%山东墨龙4.7008.45115.32%30.05%凯盛新能2.2957.18274.73%24.65%晨鸣纸业0.6101.91275.41%18.37%上海电气2.9106.58170.79%17.02%京城机电股份2.8508.29248.42%16.04%沃尔核材10.07017.12103.67%14.52%中国国航3.7705.9488.59%14.33%丽珠医药19.88026.4759.51%14.26%. 备注：以上数据由智通机器人根据港交所数据，经过人工智能运算后自动生成，并不保证数据100%准确；偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0327786744.USD","02338","00042","01877","83188","03130","00991","06869","02359","01812","01349","01108","03750","00317","02827","00981","00300","03328","399300","02727","01057","03188","00568","LU0348816934.USD","02691","09981","03143","03986","00553","83130","03678","07233","06690","02846","01033","00753","03968","03200","03308","159982","01513","03296","02218","82846","EWH","03268","06185","00187","02475"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179894652","title":"一周港股牛熊榜 | 亮晴控股本周暴升62%，公司有望下月入通；东方甄选周升24%，2026财年净利暴增86倍；深演智能本周累升23%，中期净利润同比增长125.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179894652","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179894652?lang=zh_cn&edition=full","pubTime":"2026-08-29 09:21","pubTimestamp":1787966509,"startTime":"0","endTime":"0","summary":"$东方甄选$本周累升24%，2026财年净利暴增86倍，上市直播电商盈利普遍改善2026财年，东方甄选总营收57.01亿元，同比增长29.8%；经营利润6.63亿元，相较上年同期亏损1.10亿元，实现扭亏为盈。尤其值得注意的是，2026财年下半年营收达到34亿元，同比增长约53.7%，净利润同比增长196.8%，增长显著加快。$深演智能$ 本周累升23%，中期净利润同比增长125.2%至820万元深演智能发布截至2026年6月30日止六个月业绩，公司实现总收入人民币3.982亿元，同比增长43.6%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["82828","82800","00811","HSCEI","02800","HSTECH","03423","07500","83115","01400","07300","02828","00371","03032","09115","09971","03037","03033","09088","09067","07552","00100","03419","07226","03417","03067","07200","00600","02837","01513","03115","07588","03416","01797","03774","03088","07288","HSI","02723"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706353","title":"丽珠医药(01513)：莱康奇塔单抗注射液(皮下注射)获得《药品注册证书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706353","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662706353?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:37","pubTimestamp":1787827060,"startTime":"0","endTime":"0","summary":"丽珠医药(01513)发布公告，近日，公司的控股子公司珠海市丽珠单抗生物技术有限公司(丽珠单抗)收到国家药品监督管理局核准签发的《药品注册证书》(证书编号：2026S03179)","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg13.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg13.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487138.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186502237","title":"丽珠医药（01513）拟于9月8日召开董事会审议特别股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1186502237","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186502237?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:06","pubTimestamp":1787821602,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司（01513）8月27日公告称，公司董事会已决定于2026年9月8日（星期二）召开董事会会议，拟审议并批准有关派发特别股息的议案。\n公告指出，如董事会在届时通过该项建议，公司将于会后另行披露特别股息的具体安排与金额。\n公司提醒投资者，鉴于特别股息提议尚待董事会审议并可能获批或未获批，股东及潜在投资者在买卖公司证券时应保持审慎。\n截至公告披露日，公司董事会成员包括：执行董事刘大平（总裁）、唐阳刚（副董事长）；非执行董事朱保国（董事长）、林楠棋、邱庆丰；职工董事冉永梅；独立非执行董事罗会远、崔丽婕、王智瑶及康立。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662878247","title":"智通AH统计|8月25日","url":"https://stock-news.laohu8.com/highlight/detail?id=2662878247","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662878247?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:37","pubTimestamp":1787647022,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止8月25日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为1068.83%、374.66%、324.43%；宁德时代、药明康德、招商银行分列AH溢价率末三位，溢价率分别为-25.61%、-5.56%、-4.19%。其中东北电气、君正股份、康希诺生物的偏离值位居前三，分别为70.19%、56.97%、37.16%；另外，南华期货股份、长飞光纤光缆、广合科技的偏离值位居后三，分别为-57.90%、-38.35%、-25.98%。　　前十大AH股溢价率排行。　　股票名称H股(港元)A股溢价率↓偏离值","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260825/32346290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02218","01989","00956","01108","03759","00568","03968","06826","01349","82846","LU0516423174.USD","06185","03986","00981","03223","03750","LU1504937902.USD","00553","83130","00300","03296","03678","02899","01812","399300","02846","159982","02691","03130","02338","02827","01033","03328","03188","00187","00317","01057","03143","83188","01513","03308","06869","00042","02475","02768","02359","06613","07233","EWH"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2662789918","title":"港股异动 | 丽珠医药(01513)续跌超3% 二季度归母净利同比降四成 化学制剂与中药板块明显下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662789918","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662789918?lang=zh_cn&edition=full","pubTime":"2026-08-25 14:29","pubTimestamp":1787639349,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，继昨日大跌近16%后，丽珠医药续跌超3%，盘中触及20.18港元创逾两年新低。消息面上，丽珠医药近日发布2026年中期业绩，上半年实现营业收入约50亿元人民币，同比减少20.28%；归属于母公司股东的净利润9.32亿元，同比减少27.23%。单看二季度，公司实现营业收入为21.3亿元，同比下降31.1%；归母净利润为3.55亿元，同比下降44.9%。归因于今年一季度国内流感及呼吸道疾病发病率回落，导致相关产品的需求下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01513","BK4585","VXUS","BK4588","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662789913","title":"港股异动 | 丽珠医药(01513.HK)续跌超3% 二季度归母净利同比降四成 化学制剂与中药板块明显下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662789913","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662789913?lang=zh_cn&edition=full","pubTime":"2026-08-25 14:29","pubTimestamp":1787639349,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661822142","title":"港股收盘(08.24) | 恒指收跌1.89% 光通信概念重挫 阿里(09988)配股800亿全押 AI，股价大跌8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661822142","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661822142?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:28","pubTimestamp":1787560113,"startTime":"0","endTime":"0","summary":"截至收盘，恒生指数跌1.89%或492.13点，报25517.33点，全日成交额2911.51亿港元；恒生国企指数跌1.89%，报8471.36点；恒生科技指数跌3.61%，报4594.04点。光通信概念跌幅居前。截至收盘，跌15.73%，报21港元。丽珠医药上半年取得营业收入约50亿元人民币，同比减少20.28%；归属于母公司股东的净利润9.32亿元，同比减少27.23%。大金重工股价重挫。大金重工二季度实现营收13.5亿元，同比减少20.9%；归母净利1.7亿元，同比减少47.4%，环比则下降61.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02526","02833","ALBmain","BABU","BABC","SIXG","82800","VTHR","AIPO","LDEM","02800","BABW","MHImain","VXUS","ARTY","03308","07300","BABX","CHAT","HSImain","AGIX","KBAB","LUMA","FDNI","FOTO","89988","KWEB","MCHmain","07500","QTOC","01797","HSI","01513","00386","DRAG","KCAI","BBYY","CXSE","LYTE","03419","BKF","HBBD.SI","09988","BABO","ONLN","HHImain","83115","513600","BABA","CLIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661722193","title":"港股异动丨丽珠医药放量大跌近17%，上半年少赚27.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661722193","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661722193?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:17","pubTimestamp":1787559422,"startTime":"0","endTime":"0","summary":"丽珠医药(1513.HK)今日放量大跌，盘中一度跌近17%至20.76港元，股价创2024年2月以来新低，截至目前成交额放大至1.6亿港元。消息面上，公司公布，截至今年6月底止中期业绩，营业收入近50亿元，同比跌20.28%；股东应占盈利9.32亿元，同比下跌27.23%；每股盈利1.05元；不派中期息。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/24/20260824754921.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/24/20260824754921.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260824/32344854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1191","01513","BK4585","VXUS","BK4588","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661024235","title":"港股异动 | 丽珠医药(01513.HK)大跌超16% 上半年营收、净利双降 化学制剂与中药制剂业绩大幅下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2661024235","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661024235?lang=zh_cn&edition=full","pubTime":"2026-08-24 09:51","pubTimestamp":1787536312,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01513","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150032597","title":"丽珠医药(01513)1.07亿元增持核心子公司新北江制药股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1150032597","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150032597?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:25","pubTimestamp":1787307942,"startTime":"0","endTime":"0","summary":"8月22日，丽珠医药集团股份有限公司公告称，于8月21日与珠海中汇源投资合伙企业及丽珠集团新北江制药股份有限公司签署《股份转让协议》，拟以1.07亿元受让中汇源持有的新北江制药3.5044%股权。交易完成后，丽珠医药对新北江制药的持股比例将由87.1399%提升至90.6443%；中汇源持股比例由8.4368%降至4.9324%。新北江制药为丽珠医药原料药板块核心子公司。交易完成后，新北江制药仍为公司控股子公司，继续纳入合并报表范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.livzon.com.cn","stockEarnings":[{"period":"1week","weight":0.0416},{"period":"1month","weight":-0.2062},{"period":"3month","weight":-0.1527},{"period":"6month","weight":-0.2056},{"period":"1year","weight":-0.4145},{"period":"ytd","weight":-0.2145}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":-0.0137},{"period":"3month","weight":0.0373},{"period":"6month","weight":-0.0155},{"period":"1year","weight":-0.0124},{"period":"ytd","weight":-0.0122}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"丽珠医药集团股份有限公司是一家主要从事医药产品的研发、生产及销售业务的中国公司。该公司的主要业务包括化学制剂、生物制品、原料药及中间体、中药制剂、诊断试剂和设备，以及商业发展和职能管理。该公司的主要产品品牌包括“壹丽安”（艾普拉唑肠溶片及注射用艾普拉唑钠）、“丽珠得乐”（枸橼酸铋钾）系列产品、“丽倍乐”（雷贝拉唑钠肠溶胶囊）、“维三联”（枸橼酸铋钾片/替硝唑片/克拉霉素片）、“贝依”（注射用醋酸亮丙瑞林微球）、“丽申宝”（注射用尿促卵泡素）、“乐宝得”（注射用尿促性素）、“丽福康”（注射用伏立康唑）等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.001127},{"month":2,"riseRate":0.538462,"avgChangeRate":0.025406},{"month":3,"riseRate":0.538462,"avgChangeRate":0.02244},{"month":4,"riseRate":0.692308,"avgChangeRate":0.031866},{"month":5,"riseRate":0.384615,"avgChangeRate":0.007594},{"month":6,"riseRate":0.461538,"avgChangeRate":-0.00234},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.010332},{"month":8,"riseRate":0.461538,"avgChangeRate":-0.017344},{"month":9,"riseRate":0.5,"avgChangeRate":0.015712},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.019818},{"month":11,"riseRate":0.583333,"avgChangeRate":0.034244},{"month":12,"riseRate":0.5,"avgChangeRate":-0.008144}],"exchange":"SEHK","name":"丽珠医药","nameEN":"LIVZON PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供丽珠医药(01513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"丽珠医药,01513,丽珠医药股票,丽珠医药股票老虎,丽珠医药股票老虎国际,丽珠医药行情,丽珠医药股票行情,丽珠医药股价,丽珠医药股市,丽珠医药股票价格,丽珠医药股票交易,丽珠医药股票购买,丽珠医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供丽珠医药(01513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}